Potential Benefits of a Cardiovascular Polypill in Long COVID Patients

Arch Bronconeumol. 2024 May;60(5):263-264. doi: 10.1016/j.arbres.2024.02.003. Epub 2024 Feb 13.
[Article in English, Spanish]
No abstract available

Publication types

  • Letter
  • Editorial

MeSH terms

  • Aged
  • COVID-19 Drug Treatment*
  • COVID-19* / complications
  • COVID-19* / prevention & control
  • Cardiovascular Agents / administration & dosage
  • Cardiovascular Agents / therapeutic use
  • Cardiovascular Diseases / prevention & control
  • Drug Combinations
  • Female
  • Humans
  • Male
  • SARS-CoV-2

Substances

  • Drug Combinations
  • Cardiovascular Agents